- Home
- APWC vs BRNS Comparison
APWC vs BRNS Comparison
Compare APWC & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APWC
- BRNS
- Stock Information
- Founded
- APWC 1996
- BRNS 2016
- Country
- APWC Taiwan
- BRNS United Kingdom
- Employees
- APWC N/A
- BRNS N/A
- Industry
- APWC Telecommunications Equipment
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- APWC Industrials
- BRNS Health Care
- Exchange
- APWC Nasdaq
- BRNS Nasdaq
- Market Cap
- APWC 30.1M
- BRNS 28.2M
- IPO Year
- APWC 1997
- BRNS 2021
- Fundamental
- Price
- APWC $1.62
- BRNS $0.82
- Analyst Decision
- APWC
- BRNS Strong Buy
- Analyst Count
- APWC 0
- BRNS 2
- Target Price
- APWC N/A
- BRNS $3.00
- AVG Volume (30 Days)
- APWC 3.7K
- BRNS 25.9K
- Earning Date
- APWC 03-31-2025
- BRNS 05-12-2025
- Dividend Yield
- APWC N/A
- BRNS N/A
- EPS Growth
- APWC N/A
- BRNS N/A
- EPS
- APWC 0.17
- BRNS N/A
- Revenue
- APWC $472,672,000.00
- BRNS $14,969,000.00
- Revenue This Year
- APWC N/A
- BRNS N/A
- Revenue Next Year
- APWC N/A
- BRNS N/A
- P/E Ratio
- APWC $9.17
- BRNS N/A
- Revenue Growth
- APWC 11.02
- BRNS 1766.46
- 52 Week Low
- APWC $1.24
- BRNS $0.64
- 52 Week High
- APWC $2.02
- BRNS $2.60
- Technical
- Relative Strength Index (RSI)
- APWC 54.52
- BRNS 51.00
- Support Level
- APWC $1.55
- BRNS $0.68
- Resistance Level
- APWC $1.65
- BRNS $0.97
- Average True Range (ATR)
- APWC 0.08
- BRNS 0.08
- MACD
- APWC 0.01
- BRNS 0.02
- Stochastic Oscillator
- APWC 75.00
- BRNS 54.79
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.